SARS-CoV-2 evades natural killer cell cytotoxic responses

In a recent study posted to the bioRxiv* preprint server, researchers at Stanford University School of Medicine revealed the mechanism via severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) escapes natural killer (NK) cell cytotoxic reactions.

Infographic: How SARS-CoV-2 Immune Responses May Differ by Sex

The Emergence of NK Cell-Based Treatment in Cancer Immunotherapy

Challenges in αCD38-chimeric antigen receptor (CAR)-expressing natural killer (NK) cell-based immunotherapy in multiple myeloma: Harnessing the CD38dim phenotype of cytokine-stimulated NK cells as a strategy to prevent fratricide - Cytotherapy

Natural killer cell exhaustion in SARS-CoV-2 infection - Janet Gallardo-Zapata, Carmen Maldonado-Bernal, 2022

The Development of Natural Killer Cells for Solid Tumor Treatment

Infection and pathogenesis of SARS-CoV2: an immunological perspective, Book

COVID-19: Immunology, vaccines and epidemiology: Week 2: 1.5 - OpenLearn - Open University

SARS-CoV-2 evades natural killer cell cytotoxic responses

Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we?, Cell Communication and Signaling

The land-scape of immune response to monkeypox virus - eBioMedicine

Natural killer cells in antiviral immunity